Zhejiang Xinguang Pharmaceutical Co., Ltd.

¥14.55As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300519Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.71%)
Div yield 2.06%
ROE 8.68%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.38
PE TTM 31.54
TSR TTM (7.68%)
Mkt cap ¥2.328B
ROIC 63.22%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥14
(1.83%)
(25.57%)
Hold 5|9|2|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.18
0.19
0.21
17.72%
16.72%
11.89%
21.22%
Revenue¥M
135.8
140.2
142.6
140.8
1.03%
3.83%
2.71%
2.67%
Peers (US$349.0M)
Cap (US$)
PE
344.9M
—
332.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.276
—
—
EBIT/Intx
2.835
0.195
0.186
Own earn%
(147.66)
(42.94)
(43.56)
Sh yield%
36.29
26.93
27.53
Owners
Insiders/Inst%
8.65
66.95
Short interest%
3.77
SBC / revenue%
1.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
27–35
$1 testx
—
Incr. ROIC%
20